Inflammation and immunology

Comprehensive immunological profiling

Inflammation is a major driver in numerous diseases, from infections to autoimmune disorders and cancer. At Nuvisan, our state-of-the-art in vitro and in vivo/ex vivo model systems, including advanced co-cultures, offer precise and tailored solutions to thoroughly assess inflammation and immunology-related queries. Our cutting-edge approach helps expedite the identification and development of innovative therapies.

Inflammatory signalling is dependent on a plethora of distinct immune cell subsets

Our immunology platform

By integrating data from advanced tools and technologies, such as spectral flow cytometry, cytokine profiling, (humanised) mouse models and customised functional assays, our immunology platform offers a profound understanding of immune responses at both cellular and molecular levels. These capabilities are essential for identifying novel targets and biomarkers, enhancing diagnostics and evaluating therapeutic responses.

LEARN MORE

Immunology and inflammation in vivo models

We offer a comprehensive range of inflammatory and autoimmune in vivo models, covering diseases affecting the human body, including joints, skin, lungs, liver and peritoneum. We provide various application routes for your drug candidate and offer flexible study designs tailored to your specific needs. Our high-quality assessments include in vivo efficacy, relevant biomarkers, histopathology and pharmacokinetic (PK) evaluations. Our team of experienced Nuvisan scientists specialises in inflammation and autoimmune disease models, helping ensure the success of your drug discovery program.

LEARN MORE

Our immuno-oncology in vivo models

By partnering with us, you gain access to a comprehensive portfolio of customised services to accelerate your immuno-oncology project. Leveraging our extensive industry experience, we provide expert advice and conduct the most appropriate studies to advance your immuno-oncology program from exploratory stages through to the preclinical and clinical phases.

LEARN MORE

Unlock disease insights with our human iPSC platform

Take advantage of our iPSC models to explore human disease pathogenesis and progression. We provide models for drug efficacy testing, with a particular focus on cardiology and neurology. To evaluate neuronal inflammation and cellular crosstalk, we also offer iPSC-derived microglia. Our scientists are available to discuss additional indications and customise solutions to meet your specific needs.

LEARN MORE

Contact us

Nuvisan is committed to protecting your privacy, and we'll only use your personal information to administer your account and to provide the products and services you requested from us. If you consent to us contacting you for this purpose, please tick below to say how you would like us to contact you:

I agree to receive other communications from Nuvisan. In order to provide you the content requested, we need to store and process your personal data. If you consent to us storing your personal data for this purpose, please tick the checkbox below.

I have read and agree to Nuvisan's privacy policy. I consent to the processing of my personal data for the provision of content by Nuvisan only. I understand that I can revoke this consent at any time and exercise my rights as detailed in the Privacy Policy.*

You can unsubscribe from these communications at any time. For more information on how to unsubscribe, our privacy practices, and how we are committed to protecting and respecting your privacy, please review our Privacy Policy.

Email us

hello@nuvisan.com

Talk to us

+49 731 9840 0

Our locations

Neu-Ulm (headquarters)

Wegenerstrasse 13

89231 Neu-Ulm

Germany

Berlin

Muellerstrasse 178

13353 Berlin

Germany

Sophia Antipolis

2400 route des Colles

06410 Biot

France

Grafing

Am Feld 32

85567 Grafing

Germany

Waltrop

Im Wirrigen 25

45731 Waltrop

Germany

For concerns about pharmaceuticals or adverse drug-related events, contact us at: complaints@nuvisan.com